Table 3.
Infarct location comparison of ADC and LGE
| Reviewer #1 | Reviewer #2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| LGE | LGE | ||||||||
| FWHM | Threshold | FWHM | Threshold | ||||||
| + | - | + | - | + | - | + | - | ||
| ADC | + | 51 | 1 | 52 | 7 | 45 | 2 | 53 | 6 |
| - | 4 | 120 | 8 | 109 | 2 | 127 | 9 | 108 | |
| # segs in agreement | 171 (97%) | 161 (92%) | 172 (98%) | 161 (91%) | |||||
| Cohen’s Kappa (κ) | 0.93** | 0.81** | 0.94** | 0.81** | |||||
| Wilcoxon test (p) | NS | NS | NS | NS | |||||
| # LGE infarct segs | 55 (31%) | 60 (34%) | 47 (27%) | 62 (35%) | |||||
| # ADC infarct segs | 52 (30%) | 59 (34%) | 47 (27%) | 59 (34%) | |||||
| Sensitivity++ | 0.98 | 0.88 | 0.96 | 0.89 | |||||
| Specificity++ | 0.97 | 0.93 | 0.98 | 0.92 | |||||
| PPV++ | 0.93 | 0.87 | 0.96 | 0.85 | |||||
| NPV++ | 0.99 | 0.94 | 0.98 | 0.95 | |||||
**p < 0.0001, NS: not significant, ++LGE was gold standard, segs: segments.